May 22 (Reuters) - India's top drugmaker by revenue Sun Pharmaceutical Industries SUN.NS beat quarterly profit estimates on Friday helped by demand for company's high-margin specialty drugs used to treat complex conditions.
The Mumbai-based firm's consolidated net profit stood at 27.14 billion rupees ($283 million) for the quarter ended March 31, from 21.50 billion rupees last year.
That was above analysts' average estimate of 27.12 billion rupees, according to data compiled by LSEG.
($1 = 95.9125 Indian rupees)
(Reporting by Rishika Sadam and Kashish Tandon)
((Rishika.Sadam@thomsonreuters.com;))